These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 7670003

  • 1. Inhibitory effect of the potential endogenous benzodiazepine receptor ligand, octadecaneuropeptide (ODN), on gonadotropin-releasing hormone gene expression in the male rat brain.
    Li S, Pelletier G.
    Neuroreport; 1995 Jun 19; 6(9):1354-56. PubMed ID: 7670003
    [Abstract] [Full Text] [Related]

  • 2. Further studies on the mechanism of action of the endogenous benzodiazepine receptor ligand octadecaneuropeptide on gonadotropin-releasing hormone gene expression in the rat brain.
    Li S, Pelletier G.
    Neuroendocrinology; 1996 Aug 19; 64(2):79-84. PubMed ID: 8857601
    [Abstract] [Full Text] [Related]

  • 3. Role of adrenal and gonadal steroids in the response of GnRH gene expression to the endogenous benzodiazepine receptor ligand octadecaneuropeptide in the male rat brain.
    Li S, Givalois L, Pelletier G.
    Neuropeptides; 1997 Oct 19; 31(5):463-8. PubMed ID: 9413024
    [Abstract] [Full Text] [Related]

  • 4. Regulation of proopiomelanocortin gene expression by endogenous ligands of the GABAA receptor complex as evaluated by in situ hybridization in the rat pars intermedia.
    Garcia de Yebenes E, Li S, Pelletier G.
    Brain Res; 1997 Mar 07; 750(1-2):277-84. PubMed ID: 9098553
    [Abstract] [Full Text] [Related]

  • 5. Involvement of neurosteroids in the effect of the endogenous benzodiazepine receptor ligand octadecaneuropeptide (ODN) on gonadotropin-releasing hormone gene expression in rat brain.
    Li S, Givalois L, Pelletier G.
    J Neuroendocrinol; 1997 Mar 07; 9(3):229-33. PubMed ID: 9089474
    [Abstract] [Full Text] [Related]

  • 6. Influence of adrenal glands on the modulation of prolactin gene expression by the endogenous benzodiazepine ligand octadecaneuropeptide in the male rat pituitary gland.
    Wang H, Li S, Givalois L, Pelletier G.
    J Neuroendocrinol; 1998 Mar 07; 10(3):193-8. PubMed ID: 9576607
    [Abstract] [Full Text] [Related]

  • 7. Role of glucocorticoids in the modulation of corticotropin-releasing hormone mRNA level by the endogenous benzodiazepine receptor ligand octadecaneuropeptide in rat brain.
    Givalois L, Li S, Pelletier G.
    Neuroendocrinology; 1998 Aug 07; 68(2):98-104. PubMed ID: 9705576
    [Abstract] [Full Text] [Related]

  • 8. In vivo action of a new octadecaneuropeptide (ODN) antagonist on gonadotropin-releasing hormone gene expression in the male rat brain.
    Compère V, Li S, Leprince J, Tonon MC, Vaudry H, Pelletier G.
    Neuroscience; 2004 Aug 07; 125(2):411-5. PubMed ID: 15062983
    [Abstract] [Full Text] [Related]

  • 9. The octadecaneuropeptide-induced response of corticotropin-releasing hormone messenger RNA levels is mediated by GABA(A) receptors and modulated by endogenous steroids.
    Givalois L, Grinevich V, Li S, Garcia-De-Yebenes E, Pelletier G.
    Neuroscience; 1998 Jul 07; 85(2):557-67. PubMed ID: 9622252
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo action of a new octadecaneuropeptide antagonist on neuropeptide Y and corticotropin-releasing hormone mRNA levels in rat.
    Compère V, Li S, Leprince J, Tonon MC, Vaudry H, Pelletier G.
    Brain Res Mol Brain Res; 2005 Nov 30; 141(2):156-60. PubMed ID: 16154662
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain.
    Ferrero P, Santi MR, Conti-Tronconi B, Costa E, Guidotti A.
    Proc Natl Acad Sci U S A; 1986 Feb 30; 83(3):827-31. PubMed ID: 3456171
    [Abstract] [Full Text] [Related]

  • 14. Increased brain content of the endogenous benzodiazepine receptor ligand, octadecaneuropeptide (ODN), following portacaval anastomosis in the rat.
    Butterworth RF, Tonon MC, Désy L, Giguère JF, Vaudry H, Pelletier G.
    Peptides; 1991 Feb 30; 12(1):119-25. PubMed ID: 1646996
    [Abstract] [Full Text] [Related]

  • 15. The use of in vivo antisense oligonucleotide technology for the investigation of brain GABA receptors.
    Karle J, Witt MR, Nielsen M.
    Neurochem Int; 1997 Sep 30; 31(3):437-46. PubMed ID: 9246685
    [Abstract] [Full Text] [Related]

  • 16. Cellular and subcellular localization of an octadecaneuropeptide derived from diazepam binding inhibitor: immunohistochemical studies in the rat brain.
    Alho H, Bovolin P, Jenkins D, Guidotti A, Costa E.
    J Chem Neuroanat; 1989 Sep 30; 2(6):301-18. PubMed ID: 2482048
    [Abstract] [Full Text] [Related]

  • 17. Increased Hypothalamic Levels of Endozepines, Endogenous Ligands of Benzodiazepine Receptors, in a Rat Model of Sepsis.
    Clavier T, Besnier E, Lefevre-Scelles A, Lanfray D, Masmoudi O, Pelletier G, Castel H, Tonon MC, Compère V.
    Shock; 2016 Jun 30; 45(6):653-9. PubMed ID: 26796573
    [Abstract] [Full Text] [Related]

  • 18. An octadecaneuropeptide (ODN) derived from diazepam binding inhibitor increases aggressive interactions in mice.
    Kavaliers M, Hirst M.
    Brain Res; 1986 Sep 24; 383(1-2):343-9. PubMed ID: 3021278
    [Abstract] [Full Text] [Related]

  • 19. Diazepam binding inhibitor (DBI): a peptide with multiple biological actions.
    Costa E, Guidotti A.
    Life Sci; 1991 Sep 24; 49(5):325-44. PubMed ID: 1649940
    [Abstract] [Full Text] [Related]

  • 20. The stimulatory effect of the octadecaneuropeptide (ODN) on cytosolic Ca2+ in rat astrocytes is not mediated through classical benzodiazepine receptors.
    Gandolfo P, Patte C, Leprince J, Thoumas JL, Vaudry H, Tonon MC.
    Eur J Pharmacol; 1997 Mar 19; 322(2-3):275-81. PubMed ID: 9098698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.